Disease-causing V2 vasopressin receptors are retained in different compartments of the early secretory pathway

被引:63
作者
Hermosilla, R
Oueslati, M
Donalies, U
Schönenberger, E
Krause, E
Oksche, A
Rosenthal, W
Schülein, R
机构
[1] Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany
[2] Charite, Inst Pharmakol, D-14195 Berlin, Germany
关键词
bafilomycin A1; endoplasmic reticulum; endoplasmic reticulum/Golgi intermediate compartment; G protein-coupled receptor; V2 vasopressin receptor;
D O I
10.1111/j.1600-0854.2004.00239.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The G protein-coupled V-2 vasopressin receptor is crucially involved in water reabsorption in the renal collecting duct. Mutations in the human V-2 vasopressin receptor gene cause nephrogenic diabetes insipidus. Many of the disease-causing mutants are retained intracellularly by the quality control system of the early secretory pathway. It was previously thought that quality control system is restricted to the endoplasmic reticulum (ER). Here, we have examined the retention mechanisms of eight V-2 vasopressin receptor mutants. We show that mutants L62P, DeltaL62-R64 and S167L are trapped exclusively in the ER. In contrast, mutants R143P, Y205C, InsQ292, V226E and R337X reach the ER/Golgi intermediate compartment (ERGIC) and are rerouted to the ER. The ability of the mutant receptors to reach the ERGIC is independent of their expression levels. Instead, it is determined by their folding state. Mutant receptors in the ERGIC may be sorted into retrograde transport vesicles by an interaction of an RXR motif in the third intracellular loop with the coatomer complex I. Our data show that disease-causing mutants of a particular membrane protein may be retained in different compartments of the early secretory pathway and that the folding states of the proteins determine their retention mechanism.
引用
收藏
页码:993 / 1005
页数:13
相关论文
共 41 条
[1]   SEQUENTIAL COUPLING BETWEEN COPII AND COPI VESICLE COATS IN ENDOPLASMIC-RETICULUM TO GOLGI TRANSPORT [J].
ARIDOR, M ;
BANNYKH, SI ;
ROWE, T ;
BALCH, WE .
JOURNAL OF CELL BIOLOGY, 1995, 131 (04) :875-893
[2]   Traffic jam: A compendium of human diseases that affect intracellular transport processes [J].
Aridor, M ;
Hannan, LA .
TRAFFIC, 2000, 1 (11) :836-851
[3]   ER protein quality control and proteasome-mediated protein degradation [J].
Brodsky, JL ;
McCracken, AA .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1999, 10 (05) :507-513
[4]   The chaperone environment at the cytoplasmic face of the endoplasmic reticulum can modulate rhodopsin processing and inclusion formation [J].
Chapple, JP ;
Cheetham, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (21) :19087-19094
[5]   Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome [J].
Ficker, E ;
Dennis, AT ;
Obejero-Paz, CA ;
Castaldo, P ;
Taglialatela, M ;
Brown, AM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (12) :2327-2337
[6]   QUALITY-CONTROL IN THE SECRETORY PATHWAY [J].
HAMMOND, C ;
HELENIUS, A .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (04) :523-529
[7]  
Hauri HP, 2000, J CELL SCI, V113, P587
[8]   Sorting functions of the individual cytoplasmic domains of the G protein-coupled vasopressin V2 receptor in the Madin Darby canine kidney epithelial cells [J].
Hermosilla, R ;
Schülein, R .
MOLECULAR PHARMACOLOGY, 2001, 60 (05) :1031-1039
[9]   Aggresomes: A cellular response to misfolded proteins [J].
Johnston, JA ;
Ward, CL ;
Kopito, RR .
JOURNAL OF CELL BIOLOGY, 1998, 143 (07) :1883-1898
[10]   Grp78 is involved in retention of mutant low density lipoprotein receptor protein in the endoplasmic reticulum [J].
Jorgensen, MM ;
Jensen, ON ;
Holst, HU ;
Hansen, JJ ;
Corydon, TJ ;
Bross, P ;
Bolund, L ;
Gregersen, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33861-33868